BEYRIZO

Welcome to the Brand page for “BEYRIZO”, which is offered here for Pharmaceutical products for use in the field of neuroscience, for the treatment of neurological and nervous system diseases and disorders; pharmaceutical preparations for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome;.

Its status is currently believed to be active. Its class is unavailable. “BEYRIZO” is believed to be currently owned by “TAKEDA PHARMACEUTICALS INTERNATIONAL AG”.


Owner:
TAKEDA PHARMACEUTICALS INTERNATIONAL AG
Owner Details
Description:
Pharmaceutical products for use in the field of neuroscience, for the treatment of neurological and nervous system diseases and disorders; pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome;
Categories: PHARMACEUTICAL PRODUCTS USE